ARYx Therapeutics Inc. (NASDAQ: ARYX) announced that the database for the EmbraceAC study has been locked and the study remains ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE